Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C

The COVID-19 pandemic has impacted the care of countless individuals, including pediatric oncology patients. The initial lack of knowledge about the disease course and implications of infection led to delays in treatment to minimize additional harm. In pediatric oncology, unnecessary delays in chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Kayleigh M., Honstain, Chelsea, Spruit, Jessica L., Harris, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801970/
https://www.ncbi.nlm.nih.gov/pubmed/35256228
http://dx.doi.org/10.1016/j.pedhc.2022.01.006
Descripción
Sumario:The COVID-19 pandemic has impacted the care of countless individuals, including pediatric oncology patients. The initial lack of knowledge about the disease course and implications of infection led to delays in treatment to minimize additional harm. In pediatric oncology, unnecessary delays in chemotherapy or hematopoietic stem cell transplantation may increase the risk of disease relapse. This case report describes one high-risk pediatric oncology patient's clinical course through hematopoietic stem cell transplantation immediately following COVID-19 infection complicated by multisystem inflammatory syndrome in children. The disease course, monitoring, long-term outcome, and recommendations for future research are reviewed.

Ejemplares similares